China-based Lifetech Scientific Corporation (HKG: 1302) announced that it has received market approval from the National Medical Products Administration (NMPA) for its aortic stent graft system, co-developed by Fuwai Hospital.
Product Overview
The aortic stent graft system is the first of its kind in China specifically designed for chimney technology. It provides a new treatment option for patients with lesions involving the aortic arch. The system is easy to operate, safe, effective, and has a wide range of anatomical adaptations.-Fineline Info & Tech
